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Flavonoids are among the most important plant metabolites. Due to their potential benefits, there is a considerable 
interest in this natural product. In genus Citrus, some plants have not yet been much exploited in Brazil, as in the case of 
grapefruit (Citrus maxima), whose main flavonoids are naringin and their aglycone naringenin. The physico-chemical 
characteristics are important pre-requisites of reference chemical in future studies. In this context, the objective of this 
study was to determine the characterization of naringin and naringenin by melting point, DSC, UV-VIS, 
1
H and 
13
C 
NMR, IR and MS. Results revealed that, naringin and naringenin after characterization, can be used in future studies and 
contribute to seeking possible technological applications. 
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Introduction 
Medicinal plants are a major source for the 
production of new drugs. Although only 
approximately 10% of the world biodiversity has been 
explored, 140 thousand intermediate metabolites have 
been isolated and characterized, but not yet 
biologically evaluated (1,2).
 
The study of flavonoids 
arose as a search for new compounds to develop new 
raw materials and active substances as the prototype 
of new drugs (3).
 
A few plants of the Citrus genus have not yet been 
much explored, as in the case of grapefruit (Citrus 
maxima). The main grapefruit flavonoids are naringin 
((+/-) 4’5,7-trihydroxyflavanone 7-rhamnoglucoside) 
(C27H32O14), with a molecular mass of 580.53 g mol
-1
; 
and its aglycone,  naringenin ((+/-) 4’5,7-
trihydroxyflavanone) (C15H12O5), with a molecular 
mass of  272.25 g mol
-1
 (4,5). 
Structurally the flavonoids have a diphenylpropane 
skeleton (C6-C3-C6), containing 15 atoms of carbon 
and substitution in one or more hydroxyls, including 
derivates linked to sugars. Their chemical structure 
comprises two aromatic rings (A and B) that are 
joined by a heterocyclic ring, ring C (6-8). 
Naringin and naringenin belong to the subclass of 
flavanones, with a carbonyl in position 4 of ring C and 
a saturated link in position 3. In ring B there is a 
hydroxyl in position 4’. What distinguishes them 
structurally is that naringin in position 7 of ring A 
presents a disaccharide constituted by a glucose 
molecule and another of ramnose, and in naringenin 
there is a hydroxyl (Figure 1) (6-8). 
 
Figure 1 Chemical structure of naringin (a) and naringenin 
(b). 
In the literature, several studies show important 
biological/pharmacological effects of these two 
flavonoids, such as their vasorelaxant, antioxidant, 
phosphodiesterase inhibitor, antiteratogenic, 
hepatoprotective, anti-inflammatory properties, lipid 
peroxidation inhibiting, and platelet aggregating, 
protective effect against cytochrome P450 3A4 
activity (9-14). 
The biochemical activities of flavonoids and their 
metabolites are related to their chemical structure 
which can change according to the substitutions in the 
three rings, including hydrogenation, hydroxylations, 
methylations, sulfatations and glycosylations (5,7,8).
 
The characterization of a pharmaceutical input 
using an adequate analytic methodology is an essential 
condition for the development of new pharmaceutical 
forms, both from the scientific and regulatory point of 
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view (8). The International Conference on 
Harmonization (ICH) (15) affirms that the purity of 
the substances used is extremely important for the 
development and validation of an analytic 
methodology.  
In this context, considering the relevance of the 
study, the objective of this study was to characterize 
naringin and naringenin using the melting point, 
differential scanning calorimetry (DSC) and 
spectroscopic techniques, such as: mass spectrometry 
(MS), nuclear magnetic resonance (NMR) of 
hydrogen (
1
H) and carbon (
13
C) and spectrometry in 
the ultraviolet (UV) and infrared (IR) region.  
 
Experimental 
Materials  
Naringin (96.6%, Sigma-Aldrich, Buchs, 
Switzerland), naringenin (99.2%, Sigma-Aldrich, 
Buchs, Switzerland), ethanol, deuterated methanol, 
acetonitrile and water. All the reagents and solvents 
used were grade p.a., supplied by Tedia
®
 and UV 
Tech
®
. 
 
Physical characteristics 
The aspect and color of the naringin and 
naringenin samples were evaluated.  
 
Determination of the melting point 
In order to determine the range of melt of naringin 
and naringenin using the capillary method, the Mettler 
Toledo®, model FP90 equipment was used. It 
determines the melting point by light transmission, 
preventing the operator from interfering in the 
procedure. Before performing the analysis the 
equipment was calibrated and immediately after this 
the samples were compacted into capillary tubes each 
(6 mm long and 1 mm diameter). The capillaries were 
introduced vertically into the equipment, with heating 
at 10 °C minute
-1
. The reading was performed in 
triplicate. 
 
Differencial scanning calorimetry 
The naringin and naringenin were analyzed in 
DSC equipment with heat flow, of Shimadzu 
(Shimadzu, Kyoto, Japan), model DSC-60, with FC-
60 flow controller, 60 WS integrator and TA 60 
(version 2.0) control and analysis software. 
Calibration was performed previously with indium 
(156.6 °C, with transition energy of 28.45 J g
-1
). 
About 1.00 mg of each of the samples was weighed, 
separately, and they were transferred to aluminum 
sample crucible, sealed and submitted to heating up to 
300 °C, with a ratio of 10 °C minute
-1
, under a 
nitrogen atmosphere. 
 
Ultraviolet spectroscopy 
Naringin and naringenin were analyzed in a UV-
1800, Shimadzu
®
 Spectrophotometer. Spectra were 
traced on the 200-400 nm wavelength, using quartz 
cuvettes with a 1 cm optical path. Ethanol with a final 
concentration of 10.0 µg ml
-1
 was used to prepare the 
solutions.  
 
Ultraviolet spectroscopy 
Naringin and naringenin were analyzed in a UV-
1800, Shimadzu
®
 Spectrophotometer. Spectra were 
traced on the 200-400 nm wavelength, using quartz 
cuvettes with a 1 cm optical path. Ethanol with a final 
concentration of 10.0 µg ml
-1
 was used to prepare the 
solutions.   
 
Infrared spectroscopy 
The spectra were obtained with the IR Shimadzu
®
 
model 8001 spectrophotometer. Approximately 1.50 
mg of naringin and naringenin were weighed 
separately. The reading was performed in the region of 
the 4,000- 600 cm cm
-1
 spectrum.  
 
Nuclear magnetic resonance spectroscopy 
The 
1
H and 
13
C NMR of naringin and naringenin 
were performed on 300 MHz, Varian equipment, 
model VNMRS-300, using deuterated methanol as a 
solvent. The chemical displacements were reported in 
ppm and the substance structures were defined based 
on the analysis of the spectroscopic data and on 
comparing the data obtained in the literature. 
 
Liquid chromatography coupled to mass 
spectrometry (UPLC-Q-TOF-MS/MS) 
The analyses were performed by liquid 
chromatography coupled to mass spectrometry 
(UPLC-Q-TOF-MS/MS). The equipment used was 
Waters Acquity Ultra Performance LC (Waters Corp., 
Milford, MA). The direct injection technique was 
employed for detection with a ionization interface by 
positive electrospray (ESI
+
), using a Zorbax RRHD 
Eclipse Plus C118 column (2.1 mm x 50 mm; 1.8 
µm). The conditions used were cone voltage 10 V; 
source temperature 110 °C; desolvation temperature 
350 °C. Ultrapure water with a pH adjusted to 4.0 with 
hydrochloric acid (A) and acetonitrile (B) was used to 
prepare the mobile phase. Separation was done in 
three minutes using gradient: 0-1.33 min 10%-70% B; 
1.33-2.00 min 70% B; 2.00-3.00 min 70%-10% B. 
The injection volume was 6.0 µl, with a flow of 0.4 ml 
minute
-1
. The stock solution was prepared with 
ethanol and dilution was performed with water at pH 
4.0 and acetonitrile (1:1) (v/v). The sample were 
filtered with a 0.22 µm nylon filter and analyzed. 
 
Results and Discussion 
Physical characteristics 
Naringin was presented in powder form and 
slightly yellow. Naringenin was presented in powder 
form in a light brown color. The descriptions of the 
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two substances are appropriate to the specifications 
informed by the manufacturer. 
 
Determination of the melting point 
The range of melt found for naringin was broad, 
from 220.1 to 249.7 °C, and for naringenin it was 
253.0 °C. For the two flavonoids there was a change 
of color, both of them began to present a brown color. 
The flavonoids containing sugar molecules, such as 
naringin, present lower melting points and greater 
molecular masses than the aglycones, such as 
naringenin (16). The results found were compared to 
those obtained with the DSC technique.  
 
Differential scanning calorimetry 
DSC is a thermoanalytic method based on the 
determination of heat that involves transitions 
classified as endothermal or exothermal. This 
technique has great applications, especially in the field 
of quality control, to characterize drugs and adjuvants, 
evaluate the finished product and perform process 
control (17,18). The onset temperature (temperature at 
which the base line is extrapolated) is the temperature 
at which a thermal event begins to be observed and it 
is more reliable than the maximum temperature which 
can be influenced by experimental factors, such as 
warming velocity (18). Figure 2 shows the heating 
curve of naringin and naringenin. 
 
Figure 2 Heating curve obtained by DSC from naringin (a) 
and naringenin (b). 
 
The DSC profile of naringin did not show a 
defined melting point. This may be occurring because 
substances with an amorphous structure do not have a 
melting point since there is no crystal lattice (19).
 
In 
the literature there are reports that naringin presents an 
endothermal melting peak at 253 °C and the peaks that 
occur after 250 °C are due to its decomposition.
20
 
Binello and collaborators (21) mention that naringin 
presented two endothermal peaks, one at 83 °C and 
one at 171 °C, corresponding to the successive loss of 
two water molecules. 
For naringenin the fusion temperature was 252.61 
°C. The fusion enthalpy (ΔH) was – 153.49 J.g-1. This 
shows an endothermal event which is represented by 
descending signals and the result is expressed through 
a negative value of the differential signal.  
The results found for naringenin corroborate those 
found in the literature. According to Lauro (20), 
Semalty (22), Sansone (23) and Yang (24) naringenin 
presents a marked endothermal peak around 253 º C. 
The peak presented as fine and without deformations, 
characteristic of a pure product (18,25). It could be 
seen that the melting point found in the analysis of 
DSC is similar to the melting range obtained by the 
capillary method for naringenin. 
 
Ultraviolet spectroscopy 
UV radiation absorption occurs by exciting 
electrons inside the molecule to a state of greater 
energy (26).
 
Ethanol was the most adequate of the 
solvents tested because both naringin and naringenin 
are soluble. Since both substances have distinct 
characteristics, naringin is polar, because in its 
structure it has the glycoside group and naringenin has 
apolar characteristics (27). 
The spectrum of the flavonoids is generally 
characterized by presenting two maximums with 
distinct absorptions, a band II in the 240-295 nm range 
and a band I in the 300-400 nm range, referring to ring 
A and B, respectively (28). The naringin and 
naringenin spectra are shown in Figure 3. The 
maximum absorption found for naringin was 285 nm 
and for naringenin 288 nm. These absorptions are 
ascribed to the absorbance of ring A in its molecular 
structures (29,30). 
 
 
Figure 3 Spectrophotometry in the ultraviolet region of 
naringin and naringenin at the concentration of 10.0 µg ml-1 
in ethanol. 
 
Infrared spectroscopy 
Spectrophotometry in the IR region is based on the 
principle of interaction of the electromagnetic 
radiation that passes through the sample and is 
absorbed by the links, leading to stretching or folding 
of these links (26).
 
The absorption spectra obtained 
from naringin and naringenin in the IR region are 
shown in Figure 4. 
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Figure 4 Spectrum in the infrared region of naringin (a) and 
naringenin (b). 
 
In order to interpret the spectra of the two 
flavonoids that are being studied, the spectrum was 
divided into two regions: between 4,000-1,300 cm
-1
 
which is the region called of functional groups and 
between 1,300-600 cm
-1
 called region of the molecule 
fingerprint. The attributions of the characteristic bands 
of the two molecules were established based on the 
literature and are described in Table 1 (27,31-34). 
Spectroscopy in the IR region enabled the 
confirmation of the naringin and naringenin flavonoid 
structure, since it was possible to confirm the presence 
of all characteristic bands.
 
 
Table 1 Attributions of the main bands of the naringin and 
naringenin spectrum. 
 
 Naringin Naringenin 
Attribution  Frequency (cm-1) 
OH (axial deformation) 3398.53 
1036.79 
3272.26 
C=O 1626.21 1626.15 
C=C 1588.47 1599.83 
Aromatics ~ 1200 ~ 1500 
Axial deformation of C-O-C 985.19 1155.39 
1081.90 
Angular deformation C-H ~800 ~800 
 
Nuclear magnetic resonance spectroscopy 
Figures 5, 6 and Table 2 show the spectra and the 
characteristic signals of 
1
H and 
13
C of naringin and 
naringenin. According to Agrawal (35), the data on 
13
C NMR are important to establish the structure of a 
glycosylated flavonoid. Based on these data it is 
possible to establish the number of sugars linked, 
nature, position and conformation.  
Naringenin presents fifteen carbons, seven 
quaternaries, seven are CH and one is CH2. The same 
occurs with naringin and there are another twelve 
carbons, one signal is attributed to methylenic carbon 
(CH2) in 60.7 ppm (C-6’’), one CH3 in 16.90 ppm (C-
6’’’) and 10 are CH. Characterizing the skeleton of a 
flavanone, the two molecules presented an 
oxymethynic group between carbons C-2 and C-3a-b 
(36-38). 
The signal of deuterated methanol is represented in 
the region of 47 ppm in the spectra, corroborating the 
literature. Analyzing the 
1
H NMR spectrum, the 
deuterated methanol is located at 3.39 and at 4.9 ppm 
(s) corroborating the literature (39). 
In ring A of the two flavanones, there are two 
signals characteristic of hydrogen atoms, with a meta 
substitution corresponding to hydrogens H6 and H8. 
In the naringenin molecule displacements at 9.41 and 
10.83 ppm are attributed to the hydrogen of the 
hydroxyl of carbon C-5 and C-7, respectively. In 
naringin, the hydroxyl of carbon C-5 is at 9.41 ppm 
(40-42). 
Ring B revealed the presence of a substituted 
aromatic para system, represented by two doublets 
7.33 ppm (H2’ and H6’) and 6.84 ppm (H3’ and H5’) 
in the naringin molecule and also two doublets at 7.31 
ppm (H2’ and H6’) and 6.83 ppm (H3’ and H5’) in the 
naringenin molecule. The hydroxyl of carbon C-4’ is 
at 12.08 ppm in both flavonoids (40-42). 
The hydrogens present in the two sugar molecules 
of naringin show signals at 1.31 (d) ppm referring to 
CH3, between 3.0 and 4.0 ppm, besides two signals 
attributed to the hydrogens linked to the anomeric 
carbons at  5.27 and 5.35 ppm (43,44). 
 
 
 
 
Figure 5 1H and 13C NMR spectrum of naringin. 
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Figure 6 1H and 13C NMR spectrum of naringenin. 
 
Table 2 1H and 13C NMR chemical shift values (ppm) of 
naringin and naringenin. 
 
 Naringin Naringenin 
Position 
13C 1H 13C 1H 
2 79.31 5.31 79.05 5.30 
3a 
3b 
42.37 
42.37 
3.89 
2.75 
42.61 
42.61 
3.09 
2.67 
4 197.23 - 196.38 - 
5 163.85 - 164.03 - 
6 96.50 6.18 95.68 5.90 
7 164.92 - 166.90 - 
8 95.50 6.18 94.80 5.90 
9 163.09 - 163.45 - 
10 103.64 - 101.94 - 
1’ 127.47 - 129.66 - 
2’ 129.27 7.33 127.68 7.31 
3’ 115.02 6.84 114.93 6.83 
4’ 157.56 - 157.57 - 
5’ 115.02 6.84 114.93 6.83 
6’ 129.27 7.33 127.68 7.31 
1’’ 92.89 5.27 - - 
2’’ 76.64 3.17 - - 
3’’ 77.77 3.44 - - 
4’’ 68.56 3.61 - - 
5’’ 72.51 3.97 - - 
6’’a-b 60.71 3.67 - - 
1’’’ 101.02 5.35 - - 
2’’’ 70.91 3.67 - - 
3’’’ 77.49 3.41 - - 
4’’’ 79.31 3.44 - - 
5’’’ 69.76 3.67 - - 
6’’’ 16.90 1.31 - - 
Liquid chromatography coupled to mass 
spectrometry (UPLC-Q-TOF-MS/MS) 
Figure 7 shows the mass spectra of naringin and 
naringenin, respectively. Under the conditions 
described, the analytes produced protoned molecules 
at 581 m/z for naringin and 273 m/z for naringenin. 
The results found corroborate what is found in the 
literature (45-47). 
 
 
 
Figure 7 Mass spectrum of naringin and naringenin. 
 
 
Conclusions 
By chemical analyses, results found in the identity 
of the two flavanones, naringin and naringenin, could 
be confirmed, corroborating what is described in the 
literature. Thus, after they have been appropriately 
characterized, they can be used as a chemical of 
reference in future studies and contribute to seeking 
possible technological applications. 
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